Upload dosage in DME treatments under scrutiny
Patients with diabetic macular oedema (DME) may need less than the usual recommended dose of three monthly injections of ranibizumab during the initial loading phase of their treatment, according to a presentation here.
“In our study group the results showed that the uploading dosage of intravitreal ranibizumab should not necessarily include three injections, as the best-corrected visual acuity and recidivism of DME was not found to be directly correlated to the number of injections,” said Tatjana Josifova MD, PhD, University Eye Clinic Basel, Basel, Switzerland.
“We advise monthly OCT and BCVA controls in order to make the decision for the need of further application of ranibizumab injections.”
Tags: intraocular pressure
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.